Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Volcano presses on with vulnerable plaque trial:

This article was originally published in Clinica

Executive Summary

Volcano Therapeutics has enrolled the first 20 patients into its international safety trial assessing its thermography catheter for detecting vulnerable plaque in coronary arteries. The study is being conducted in New Zealand, Germany and Italy and is expected to produce data to support regulatory filings for permission to commercialise the product. Investigators have so far reported that the device has performed as expected and met all safety endpoints, says the Laguna Niguel, California firm.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT068275

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel